240 related articles for article (PubMed ID: 26659000)
1. microRNA and Ovarian Cancer.
Langhe R
Adv Exp Med Biol; 2015; 889():119-51. PubMed ID: 26659000
[TBL] [Abstract][Full Text] [Related]
2. A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
Langhe R; Norris L; Saadeh FA; Blackshields G; Varley R; Harrison A; Gleeson N; Spillane C; Martin C; O'Donnell DM; D'Arcy T; O'Leary J; O'Toole S
Cancer Lett; 2015 Jan; 356(2 Pt B):628-36. PubMed ID: 25451316
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in ovarian cancer biology and therapy resistance.
van Jaarsveld MT; Helleman J; Berns EM; Wiemer EA
Int J Biochem Cell Biol; 2010 Aug; 42(8):1282-90. PubMed ID: 20083225
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
[TBL] [Abstract][Full Text] [Related]
5. The role of microRNAs in ovarian cancer.
Kinose Y; Sawada K; Nakamura K; Kimura T
Biomed Res Int; 2014; 2014():249393. PubMed ID: 25295252
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
8. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery in ovarian cancer.
Tung CS; Wong KK; Mok SC
Womens Health (Lond); 2008 Jan; 4():27-40. PubMed ID: 19072449
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.
Ma Y; Lu Y; Lu B
Cancer Invest; 2016 Oct; 34(9):465-476. PubMed ID: 27673409
[TBL] [Abstract][Full Text] [Related]
11. Current status on microRNAs as biomarkers for ovarian cancer.
Prahm KP; Novotny GW; Høgdall C; Høgdall E
APMIS; 2016 May; 124(5):337-55. PubMed ID: 26809719
[TBL] [Abstract][Full Text] [Related]
12. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
[TBL] [Abstract][Full Text] [Related]
13. Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets.
Kuznetsov VA; Tang Z; Ivshina AV
BMC Genomics; 2017 Oct; 18(Suppl 6):692. PubMed ID: 28984201
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in Ovarian Cancer.
Katz B; Tropé CG; Reich R; Davidson B
Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
[TBL] [Abstract][Full Text] [Related]
16. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.
Chen SN; Chang R; Lin LT; Chern CU; Tsai HW; Wen ZH; Li YH; Li CJ; Tsui KH
Int J Environ Res Public Health; 2019 Apr; 16(9):. PubMed ID: 31035447
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes and microRNAs involved in ovarian carcinogenesis.
Wan SM; Lv F; Guan T
Asian Pac J Cancer Prev; 2012; 13(8):3997-4000. PubMed ID: 23098506
[TBL] [Abstract][Full Text] [Related]
19. Characterization of microRNA expression in serous ovarian carcinoma.
Li Y; Yao L; Liu F; Hong J; Chen L; Zhang B; Zhang W
Int J Mol Med; 2014 Aug; 34(2):491-8. PubMed ID: 24939816
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review).
Palma Flores C; García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Astudillo de la Vega H; Marchat LA; Salinas Vera YM; López-Camarillo C
Int J Oncol; 2017 May; 50(5):1461-1476. PubMed ID: 28393213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
